EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+18.54%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$2.68B
AUM Growth
+$2.68B
(+19%)
Cap. Flow
+$339M
Cap. Flow
% of AUM
12.66%
Top 10 Holdings %
Top 10 Hldgs %
68.02%
Holding
82
New
12
Increased
16
Reduced
6
Closed
10
Top Buys
| 1 |
Alector
ALEC
|
$75.8M |
| 2 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$54.6M |
| 3 |
Relay Therapeutics
RLAY
|
$38.7M |
| 4 |
Janux Therapeutics
JANX
|
$35.2M |
| 5 |
Arcus Biosciences
RCUS
|
$31.3M |
Top Sells
| 1 |
Eledon Pharmaceuticals
ELDN
|
$11.9M |
| 2 |
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
|
$10.5M |
| 3 |
AC Immune
ACIU
|
$7.93M |
| 4 |
Neurogene
NGNE
|
$7.05M |
| 5 |
LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
|
$5.01M |
Sector Composition
| 1 | Healthcare | 98.93% |
| 2 | Financials | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$441M
| $580M | 21.68% | 11,284,280 +250,000 | +2% | +$12.9M |
|
|
MORF
2
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $227M | 8.48% | 3,951,566 +952,251 | +32% | +$54.6M |
|
3
AnaptysBio
ANAB
$569M
| $195M | 7.29% | 7,521,024 +369,400 | +5% | +$9.58M |
|
4
Xencor
XNCR
$580M
| $169M | 6.32% | 4,906,106 +5,800 | +0.1% | +$200K |
|
|
5
Relay Therapeutics
RLAY
$619M
| $164M | 6.14% | 4,487,776 +1,058,413 | +31% | +$38.7M |
|
6
Nuvation Bio
NUVB
$1.02B
| $128M | 4.77% | 13,711,517 +464,500 | +4% | +$4.32M |
|
7
Shattuck Labs
STTK
$47M
| $96.2M | 3.6% | 3,318,410 +860,151 | +35% | +$24.9M |
|
|
8
Arcus Biosciences
RCUS
$1.13B
| $91.6M | 3.42% | 3,335,247 +1,139,355 | +52% | +$31.3M |
|
|
9
Alector
ALEC
$238M
| $88.4M | 3.3% | 4,242,634 +3,640,034 | +604% | +$75.8M |
|
10
ARS Pharmaceuticals
SPRY
$1.15B
| $80.9M | 3.02% | 2,618,036 +84,401 | +3% | +$2.61M |
|
11
Kura Oncology
KURA
$686M
| $77.7M | 2.9% | 3,724,437 +31,800 | +0.9% | +$663K |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $75M | 2.8% | 464,298 | – | – |
|
13
Oric Pharmaceuticals
ORIC
$994M
| $54.7M | 2.04% | 3,092,218 | – | – |
|
14
Nurix Therapeutics
NRIX
$714M
| $52.2M | 1.95% | 1,967,950 -51,069 | -3% | -$1.35M |
|
15
Avidity Biosciences
RNA
$5.99B
| $52M | 1.94% | 2,103,950 | – | – |
|
|
16
Janux Therapeutics
JANX
$1.37B
| $35.2M | 1.32% | +1,411,975 | New | +$35.2M |
|
17
Solid Biosciences
SLDB
$427M
| $33.7M | 1.26% | 9,202,702 | – | – |
|
|
GRTS
18
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $31.2M | 1.17% | 3,421,287 | – | – |
|
|
TBIO
19
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $28.9M | 1.08% | 1,048,976 +452,076 | +76% | +$12.5M |
|
20
iTeos Therapeutics
ITOS
| $26.6M | 0.99% | 1,035,864 +775,864 | +298% | +$19.9M |
|
21
Edgewise Therapeutics
EWTX
$1.51B
| $26.1M | 0.98% | 1,224,175 | – | – |
|
22
Kymera Therapeutics
KYMR
$2.95B
| $25.2M | 0.94% | 519,416 +419,416 | +419% | +$20.3M |
|
23
Design Therapeutics
DSGN
$315M
| $25.1M | 0.94% | 1,260,019 +122,079 | +11% | +$2.43M |
|
|
AKUS
24
DELISTED
Akouos, Inc. Common Stock
AKUS
| $24.8M | 0.93% | 1,975,984 | – | – |
|
25
Arvinas
ARVN
$568M
| $24.8M | 0.93% | 321,724 +3,020 | +0.9% | +$233K |
|